On the basis of improving relevant studies, it is expected to develop inhibitors of CSNK1G2-AS1 to inhibit the migration of testicular germ tumor cells, and develop new therapeutic drugs to improve TGCT treatment. The gene discussed is CSNK1G2; the disease is testicular germ cell tumor.